Exoskeleton for Parkinson's Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the exoskeleton treatment for Parkinson's Disease?
Research shows that using an exoskeleton for gait training can improve walking distance and reduce the effort needed for people with Parkinson's Disease. Another study found that exoskeleton-assisted training improved arm movement speed and accuracy, suggesting potential benefits for motor skills.12345
What safety information is available for exoskeletons used in medical applications?
How does the exoskeleton treatment for Parkinson's disease differ from other treatments?
The exoskeleton treatment for Parkinson's disease is unique because it uses a wearable robotic device to assist with movement and improve gait, unlike traditional treatments that primarily rely on medication or surgery. This approach offers a non-invasive, mechanical method to enhance mobility and reduce symptoms, potentially increasing exercise endurance and improving daily activities.111121314
What is the purpose of this trial?
Physical therapy approaches for balance and walking deficits in Parkinson's disease (PD) have limited effectiveness, with mostly short-lasting benefits. An exoskeleton is a device that straps to the legs and provides a passive force to assist people to better ambulate. The goal of this study is to establish the feasibility and safety of a lightweight exoskeleton on mobility and fall reduction in people with PD. As most PD patients eventually require assistive mobility devices, the exoskeleton represents a new option for increased, mobility, quality of life, and independence. Qualified subjects will come to the clinic twice weekly for six weeks (12 total visits) and wear the exoskeleton device while walking under the supervision of a trained physical therapist. Study staff will also interview participants and assess their PD symptoms, quality of life, and overall mobility. This study hopes to establish exoskeletons as modern, standard of care devices, which allow people with PD to maintain more independent and productive lives.
Research Team
Mark S Baron, MD
Principal Investigator
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Eligibility Criteria
This trial is for people with Parkinson's Disease confirmed by a specialist, who can walk at least 20 minutes with an exoskeleton during screening. They should be between stages II-V of the disease and not have severe cognitive issues or other health problems like heart failure or osteoporosis. Participants must be between 5'1" and 6'3" tall, weigh less than 250 pounds, and not have any lower limb amputations.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants wear the Keeogo exoskeleton device while walking under supervision for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exoskeleton
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor